Bloxiverz
- Product NDC
- 51754-1240
- 11-digit product format
- 517541240
- Labeler code
- 51754
- Product ID
- 51754-1240_2d69cd60-50c4-4ec3-926e-4d4756ad2c94
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- neostigmine methylsulfate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Exela Pharma Sciences, LLC
- Application
- NDA204078
- Marketing category
- NDA
- Marketing start
- 2021-03-03
- Marketing end
- 0000-00-00
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b | Product name | 1 | 20231002 |
| 6c2b16d0-96e9-444e-98c5-9883cd6eb72d | Product name | 2 | 20230316 |
| 6bd95106-a412-1dad-b9cc-4cb74bfb27ce | Product name | 2 | 20230315 |
| ad279e69-d021-f6bd-1150-2b55f23832d5 | Product name | 9 | 20211014 |
| 48747306-602a-42cc-957b-5b0c69158eee | Product name | 1 | 20180604 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 290f523a-f9db-9774-b5a9-e1f908ac1782 | Product name | 1 | 20150828 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| c6b65c52-69c7-df49-550a-a50c137f6218 | Product name | 1 | 20140508 |
| db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51754-1240-1 | 2026-01-29 | C162847 | 48780-1 | 49896155-ac12-586f-e063-e6dba90add90 | These highlights do not include all the information needed to use BLOXIVERZ ® safely and effectively. See full prescribing information for BLOXIVERZ. BLOXIVERZ (Neostigmine Methylsulfate Injection), for intravenous use Initial U.S. Approval: 1939 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51754-1240-3 | Bloxiverz | 10 in 1 PACKAGE | INJECTION | 10 | 2 | |
| 51754-1240-3 | Bloxiverz | 1 in 1 CARTON | INJECTION | 1 | 2 | |
| 51754-1240-1 | Bloxiverz | 1 in 1 CARTON | INJECTION | 1 | 1 | |
| 51754-1240-1 | Bloxiverz | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION | 10 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51754-1240-1 | ML - Milliliter | 51754-1240 | 372682fa-dde2-44b7-a6ad-1f6b2684e108 | 1 | 2021-06-02 |
| 51754-1240-3 | ML - Milliliter | 51754-1240 | befc18c9-841b-4169-9b83-f5e631b1d36a | 1 | 2021-06-02 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51754-1240 | BLOXIVERZ (NEOSTIGMINE METHYLSULFATE) INJECTION [EXELA PHARMA SCIENCES, LLC] | 2 | Legacy NDC, 2 package rows | 20210508_1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a.zip |
| 51754-1240 | BLOXIVERZ (NEOSTIGMINE METHYLSULFATE) INJECTION [EXELA PHARMA SCIENCES, LLC] | 1 | Legacy NDC, 2 package rows | 20210317_761d8917-27da-4a0c-9acc-98688cbc1d46.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1429284 | Bloxiverz 1 MG/ML Injectable Solution | PSN | 1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a | 2 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | PSN | 1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a | 2 |
| 1429284 | neostigmine methylsulfate 1 MG/ML Injectable Solution [Bloxiverz] | SBD | 1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a | 2 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SCD | 1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a | 2 |
| 1429284 | Bloxiverz 1 MG/ML Injectable Solution | SY | 1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a | 2 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SY | 1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a | 2 |
| 1429284 | Bloxiverz 1 MG/ML Injectable Solution | PSN | 761d8917-27da-4a0c-9acc-98688cbc1d46 | 1 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | PSN | 761d8917-27da-4a0c-9acc-98688cbc1d46 | 1 |
| 1429284 | neostigmine methylsulfate 1 MG/ML Injectable Solution [Bloxiverz] | SBD | 761d8917-27da-4a0c-9acc-98688cbc1d46 | 1 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SCD | 761d8917-27da-4a0c-9acc-98688cbc1d46 | 1 |
| 1429284 | Bloxiverz 1 MG/ML Injectable Solution | SY | 761d8917-27da-4a0c-9acc-98688cbc1d46 | 1 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SY | 761d8917-27da-4a0c-9acc-98688cbc1d46 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 51754-1240-1 | 51754124001 | 1 VIAL, MULTI-DOSE in 1 CARTON (51754-1240-1) > 10 mL in 1 VIAL, MULTI-DOSE | 2021-03-03 | 0000-00-00 | No | No | Current | |
| 51754-1240-3 | 51754124003 | 10 CARTON in 1 PACKAGE (51754-1240-3) > 1 VIAL, MULTI-DOSE in 1 CARTON > 10 mL in 1 VIAL, MULTI-DOSE | 10 carton | 2021-03-03 | 0000-00-00 | No | No | Current |